Mix and Match of the COVID-19 Vaccine for Safety and Immunogenicity | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Mix and Match of the COVID-19 Vaccine for Safety and Immunogenicity	COVID-19, Coronaviridae Infections, Infections, Nidovirales infectious disease, Orthocoronavirinae infectious disease, RNA Virus Infections, lung disorder, pneumonia, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease, viral pneumonia	Active, not recruiting	Phase 2	2025-03-18		NCT04894435

11 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
BC Children's Hospital Research Institute	8
Canadian Center for Vaccinology	6
Canadian Immunization Research Network	6
Children's Hospital Research Institute of Manitoba	7
CHU de Quebec-Universite Laval	54
Interior Health	2
Massachusetts General Hospital	758
McGill University Health Centre/Research Institute of the McGill University Health Centre	139
Ontario Agency for Health Protection and Promotion	2
Ottawa Hospital Research Institute	121
University of Toronto	140

8 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
BC Children's Hospital Research Institute	Vancouver	Canada	7
Canadian Center for Vaccinology	Halifax	Canada	4
Children's Hospital Research Institute of Manitoba	Winnipeg	Canada	1
CHU de Québec, Université Laval	Québec	Canada	1
McGill University Health Centre Vaccine Study Centre	Montreal	Canada	1
Ottawa Hospital Research Institute, University of Ottawa	Ottawa	Canada	1
Penticton Regional Hospital	Penticton	Canada	2
Royal Inland Hospital	Kamloops	Canada	1